How To Use CPT Code 0627T

CPT 0627T describes the percutaneous injection of an allogeneic cellular and/or tissue-based product into the intervertebral disc in the lumbar region, with fluoroscopic guidance. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, and examples.

1. What is CPT Code 0627T?

CPT 0627T can be used to describe a percutaneous injection procedure in which an allogeneic cellular and/or tissue-based product is injected into the intervertebral disc in the lumbar region. This code specifically applies to the first level injected and may be performed on one side or both sides.

2. Official Description

The official description of CPT code 0627T is: ‘Percutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, unilateral or bilateral injection, with fluoroscopic guidance, lumbar; first level.’

3. Procedure

1. The provider prepares the patient for the procedure and uses fluoroscopic guidance to visualize the intervertebral disc in the lumbar region.
2. A needle is inserted percutaneously, meaning through the skin, into the intervertebral disc at the desired level.
3. An allogeneic cellular and/or tissue-based product is injected into the disc under fluoroscopic guidance.
4. The procedure may be performed on one side or both sides of the same level, depending on the patient’s condition and the provider’s judgment.

4. Qualifying circumstances

CPT 0627T is applicable to patients who require a percutaneous injection of an allogeneic cellular and/or tissue-based product into the intervertebral disc in the lumbar region. This procedure is typically performed to treat specific conditions or disorders affecting the lumbar spine. The injection must be performed with fluoroscopic guidance, and the first level injected should be reported with this code.

5. When to use CPT code 0627T

CPT code 0627T should be used when a provider performs a percutaneous injection of an allogeneic cellular and/or tissue-based product into the intervertebral disc in the lumbar region. This code specifically applies to the first level injected. If additional levels are injected, use the appropriate additional codes (+0628T, +0629T, +0630T) based on the number of additional levels.

6. Documentation requirements

To support a claim for CPT code 0627T, the provider must document the following information:

• Patient’s diagnosis or condition necessitating the procedure
• Use of fluoroscopic guidance during the procedure
• Specific level(s) of the intervertebral disc injected
• Whether the injection was performed unilaterally or bilaterally
• Details of the allogeneic cellular and/or tissue-based product used
• Date of the procedure
• Provider’s signature

7. Billing guidelines

When billing for CPT code 0627T, ensure that the procedure meets the criteria outlined in the code description. The injection should be performed with fluoroscopic guidance, and only the first level injected should be reported with this code. If additional levels are injected, use the appropriate additional codes. It is important to follow any specific billing guidelines provided by the payer or coding guidelines.

8. Historical information

CPT code 0627T was added to the Current Procedural Terminology system on January 1, 2021. There have been no updates or changes to the code since its addition.

9. Examples

1. A provider performs a percutaneous injection of an allogeneic cellular and/or tissue-based product into the intervertebral disc at the L4-L5 level in the lumbar region, using fluoroscopic guidance.
2. Using fluoroscopic guidance, a provider injects an allogeneic cellular and/or tissue-based product into the intervertebral disc at the L3-L4 level on both sides in the lumbar region.
3. A patient with degenerative disc disease undergoes a percutaneous injection of an allogeneic cellular and/or tissue-based product into the intervertebral disc at the L5-S1 level, guided by fluoroscopy.
4. Under fluoroscopic guidance, a provider performs a percutaneous injection of an allogeneic cellular and/or tissue-based product into the intervertebral disc at the L2-L3 level unilaterally in the lumbar region.
5. A provider administers a percutaneous injection of an allogeneic cellular and/or tissue-based product into the intervertebral disc at the L1-L2 level bilaterally, using fluoroscopic guidance.
6. Using fluoroscopy, a provider performs a percutaneous injection of an allogeneic cellular and/or tissue-based product into the intervertebral disc at the L4-L5 level unilaterally in the lumbar region.
7. A patient with a herniated disc undergoes a percutaneous injection of an allogeneic cellular and/or tissue-based product into the intervertebral disc at the L3-L4 level, guided by fluoroscopy.
8. Under fluoroscopic guidance, a provider injects an allogeneic cellular and/or tissue-based product into the intervertebral disc at the L5-S1 level on both sides in the lumbar region.
9. A provider performs a percutaneous injection of an allogeneic cellular and/or tissue-based product into the intervertebral disc at the L2-L3 level unilaterally, using fluoroscopy.
10. Using fluoroscopic guidance, a provider administers a percutaneous injection of an allogeneic cellular and/or tissue-based product into the intervertebral disc at the L1-L2 level bilaterally in the lumbar region.